These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25249046)

  • 1. Pharmacotherapy of type 2 diabetes mellitus: an update on drug-drug interactions.
    Amin M; Suksomboon N
    Drug Saf; 2014 Nov; 37(11):903-19. PubMed ID: 25249046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-insulin anti-diabetic drugs: An update on pharmacological interactions.
    Ruscica M; Baldessin L; Boccia D; Racagni G; Mitro N
    Pharmacol Res; 2017 Jan; 115():14-24. PubMed ID: 27838511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of potential drug-drug interactions with antidiabetic drugs.
    Samardzic I; Bacic-Vrca V
    Pharmazie; 2015 Jun; 70(6):410-5. PubMed ID: 26189304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antidiabetic drugs and drug interactions].
    Griese-Mammen N; Gerdemann A
    MMW Fortschr Med; 2012 Oct; 154(17):65-8. PubMed ID: 23088041
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinically important effects of oral antidiabetic drug interactions].
    Drzewoski J; Kopff B
    Pol Merkur Lekarski; 2000 Sep; 9(51):605-7. PubMed ID: 11126985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions of clinical importance with antihyperglycaemic agents: an update.
    Scheen AJ
    Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
    Hu M; Zheng C; Gao F
    Drug Des Devel Ther; 2016; 10():3983-3994. PubMed ID: 27994440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study.
    Rwegerera GM
    Pan Afr Med J; 2014; 17():252. PubMed ID: 25309652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular safety of anti-diabetic drugs.
    Kumar R; Kerins DM; Walther T
    Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):32-43. PubMed ID: 27533060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the treatment of type 2 diabetes mellitus.
    Israili ZH
    Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-drug interactions with sodium-glucose cotransporters type 2 (SGLT2) inhibitors, new oral glucose-lowering agents for the management of type 2 diabetes mellitus.
    Scheen AJ
    Clin Pharmacokinet; 2014 Apr; 53(4):295-304. PubMed ID: 24420910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological management of glycemic control in the geriatric patient with type 2 diabetes mellitus.
    Neumiller JJ; Setter SM; Gates BJ; Sonnett TE; Dobbins EK; Campbell K
    Consult Pharm; 2009 Jan; 24(1):45-63. PubMed ID: 19275459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of Metformin and Hypoglycemic Therapies.
    Akhter MS; Uppal P
    Adv Chronic Kidney Dis; 2020 Jan; 27(1):18-30. PubMed ID: 32146997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Plosker GL; Faulds D
    Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hypoglycemia associated with levofloxacin in Type 2 diabetic patients receiving polytherapy: two case reports.
    Micheli L; Sbrilli M; Nencini C
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):302-6. PubMed ID: 22456302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of multiple antidiabetic medications in patients with diabetes and its association with hypoglycaemic events: a case-crossover study in Jordan.
    Naser AY; Wong ICK; Whittlesea C; Beykloo MY; Man KKC; Lau WCY; Hyassat DA; Wei L
    BMJ Open; 2018 Nov; 8(11):e024909. PubMed ID: 30467136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic effects of anti-diabetic drugs: A comprehensive review.
    Nath M; Bhattacharjee K; Choudhury Y
    Eur J Pharmacol; 2020 Oct; 884():173349. PubMed ID: 32650008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic medications in patients with type 2 diabetes mellitus and severe renal impairment: an update.
    Aperis G
    J Ren Care; 2012 Sep; 38(3):170-1. PubMed ID: 22883390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.